Race Oncology Limited (ASX:RAC) shareholders might be concerned after seeing the share price drop 25% in the last quarter. But that scarcely detracts from the really solid long term returns generated ...
Race Oncology recently held a special call to discuss a breakthrough discovery in composition of matter intellectual property linked to its research pipeline. This development could potentially ...
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. An announcement from Race Oncology Ltd. ( (AU:RAC)) is now available. Racura Oncology will host ...
If you have ever followed Race Oncology (ASX:RAC), the past week was hard to miss. The company’s announcement about a breakthrough discovery in the composition of chemotherapy drug Bisantrene turned ...
Preclinical work in the past year has demonstrated the drug’s potent cancer killing effect Special Report: Race Oncology said FY24 has been momentous for the company, which has made significant ...
Race Oncology Ltd. (AU:RAC) has released an update. Race Oncology Ltd has announced the application for quotation of 641,804 new ordinary fully paid securities on the ASX, under the code RAC, with the ...
ASX company news and announcements for Racura Oncology Ltd (RAC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Racura Oncology Ltd ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results